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doi:10.1016/j.jmii.2012.03.005Community-associated methicillin resistant Staphylococcus aureus (CA-MRSA) has been
increasingly reported recently and has become an emerging pathogen of infective endocarditis
(IE) in adults, but still rarely reported in children. A previously healthy preschool child without
any heart anomaly developed IE and pneumonia with pleural effusion. Blood cultures repeat-
edly yielded MRSA and did not become negative until 13 days after a teicoplanin-containing
regimen was administered. In total, a 4-week intravenous antibiotic therapy and an additional
8-week oral antibiotic therapy were given. The patient recovered uneventfully. All five MRSA
blood isolates were molecularly characterized and shared common characteristics, which were
consistent with those of the endemic CA-MRSA clone in Taiwan. This case highlights that physi-
cians should be aware of the growing role of CA-MRSA in childhood IE and should meticulously
choose an appropriate empiric antibiotic regimen for such a severe disease.
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Methicillin-resistant Staphylococcus aureus (MRSA) is
usually considered a nosocomial pathogen, but is increas-
ingly acquired in the community. The term “community-
associated” (CA) MRSA infection was defined to describe
a community-onset infection without any risk factor for
acquisition of MRSA,1,2 which include a history of hospital-
ization, surgery, dialysis, a permanent indwelling catheter
or percutaneous medical device, and a history of residence
in a long-term care facility within the past 12 months.
CA-MRSA strains have been recognized as novel patho-
gens which are genetically different from hospital-
acquired-MRSA strains.1,2 They are usually characterized
by limited antibiotic resistance (except to b-lactams) and
carry type IV or V staphylococcal cassette chromosome
(SCCmec IV, V); major clinical manifestations are usually
cellulitis and abscess.1e4 However, CA-MRSA clones vary in
different continents, countries, and even areas.
Aside from skin and soft tissue infection, CA-MRSA has
also been implicated in many invasive diseases, including
bacteremia, osteomyelitis, septic arthritis, and necrotizing
pneumonia.4 Since the epidemic of CA-MRSA worldwide,
there have been increasing reports of infective endocarditis
(IE) caused by CA-MRSA in adult patients; however, only
a few cases have been reported in children.5e7 In this
paper, we report a previously healthy preschool child with
IE caused by CA-MRSA carrying PantoneValentine leukoci-
din (PVL genes.
Case report
A 2-years-8-month-old previously healthy boy presented to
the Chang Bing Show Chwan Memorial Hospital with an
intermittent spike fever, irritability, and generalized itch-
ing with erythematous rashes for at least 5 days. There
were no other associated symptoms including cough, rhi-
norrhea, or diarrhea. The patient had handefootemouth
disease 2 weeks before this episode. Otherwise, his mother
denied any underlying diseases or history of allergies.
At presentation, the boy was febrile and irritable. His
body temperature was 37.5C, his blood pressure 121/
71 mmHg, pulse rate 150/min, respiratory rate 35/min, and
peripheral oxygen saturation 90e92% in room air (air
conditioned). Physical examinations revealed mild to
moderate respiratory distress, erythroderma over trunk,
desquamation of both soles and two crusty unhealed fissures
of both big toes, and a grade 2e3/6 systolic murmur on the
left sternal border. Laboratory investigations revealed
a white blood cell count of 10 109/L, with 74% neutrophils,
3% lymphocytes, 15% band form; hemoglobin 10.6 g/dL, and
a platelet count of 70 109/L. The serum C-reactive protein
level was 19.3 mg/dL (normal, <0.5 mg/dL). A chest
radiograph demonstrated some faint patches over both lung
fields, but more marked on the right side. He was admitted,
and subsequently received intravenous cefazolin and clin-
damycin therapy. Spike fever, irritability, and progressive
tachypnea were noted on the 1st hospital day. Two sets of
blood cultures grew MRSA within 24 hours. Under the
suspicion of sepsis or toxic shock syndrome, he was referred
to a medical center for intensive care on the 2nd day.On admission there, the repeated laboratory examina-
tions showed a peripheral leukocytes count of 15.8  109/L,
hemoglobin of 10.7 g/dL, and platelet count of 29  109/L.
Right-side pneumonia patches with pleural effusion were
found. He received intravenous teicoplanin and cefotaxime
therapy initially. A chest tube was inserted on hospital day
4 due to progressive tachypnea. Pleural fluid analysis was
consistent with exudates but was sterile. Transthoracic
echocardiography disclosed mild tricuspid regurgitation,
normal LV function, and two vegetations found on the right
ventricle: one at tricuspid valve with a size of 16.1 
8.2 mm and another at interventricular septum with a size
of 96.9  4.7 mm (Fig. 1). IE was confirmed. On hospital day
7, one episode of generalized tonic seizure was recorded.
No embolic event or focal lesion was found by brain
magnetic resonance image. Cerebrospinal fluid analyses
were within normal limits. Blood cultures obtained on
the 2nd, 4th and 7th hospital days all grew MRSA with the
same antibiogram. The isolate was susceptible to vanco-
mycin, teicoplanin, linezolid, rifampin, levofloxacin, and
trimethoprim-sulfamethoxazole but resistant to clindamy-
cin and penicillin. The antimicrobial regimen was switched
to intravenous teicoplanin plus intravenous trimethoprim-
sulfamethoxazole on the 10th hospital day. The chest tube
was removed on the 11th hospital day. Blood cultures turned
negative since the 13th hospital day. Finally, his fever
subsided on the 17th hospital day. He then received a 4-
week course of intravenous teicoplanin with the addition
of a 2-week course of intravenous trimethoprim-
sulfamethoxazole while hospitalized. A follow-up echocar-
diography showed that both vegetations decreased in size.
He was discharged on hospital day 30. He received
sequential oral trimethoprim-sulfamethoxazole for an
additional 8 weeks. Echocardiography performed 3 months
after discharge showed no signs of vegetations. No disease
recurrence was noted at a half-year follow-up.
All five MRSA isolates from the patient were molecularly
characterized. The detection of PVL genes, staphylococcal
chromosome cassette (SCCmec) typing, multilocus sequence
typing, and pulsed-field gel electrophoresis were performed
and determined using methods described elsewhere.4 All
isolates shared common characteristics and were charac-
terized as multilocus sequence type (ST) 59, SCCmec type
VT, and PVL genes-positive. The pulsed-field gel electro-
phoresis type belonged to type D in our previous classifica-
tion. These characteristics were consistent with those of
CA-MRSA isolates in Taiwan.Discussion
IE is a rare but severe illness in children. S aureus was the
predominant pathogen and accounted for 40e57% of pedi-
atric IE cases.8,9 Although pre-existing congenital heart
diseases remained as the major risk factor for childhood
IE, there were growing indications of a continuous shift of
IE among children without cardiac anomaly.8,9 Childhood IE
without congenital heart diseases was more often seen in
older children, compared with those who have heart
diseases.9,10 Clinically, there are no distinct differences in
terms of symptoms and signs between those caused by S
aureus and non-S aureus.6,11 The morbidity is significant,
Figure 1. A transthoracic echocardiogram showed two vegetations in the right ventricle (yellow arrow): one at the tricuspid
valve (right, 16.1  8.2 mm) and another one at the interventricular septum (left, 96.9  4.7 mm).
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identificationofaprobable case is crucial fora goodoutcome.
Since it was identified, CA-MRSA has been a recognized
emerging pathogen for IE.6 Most reported cases of IE caused
by CA-MRSA occurred in adults without valvular anomaly
and without any known predisposing factors for IE. Preex-
isting skin lesions and intravenous drug abuse were the
major risk factors. Tricuspid valve was the most common
involved site, followed by mitral and aortic valves. Events
due to embolisms were seen in 68.4% of the reported
cases.6 In the present case, the patient had no preexisting
cardiac anomaly. Two crusty partially healed fissures on
both his big toes were found. It was presumed that S aureus
invaded through these skin defects and led to IE. Both
cardiac vegetations were found at the right ventricle, with
one at the tricuspid valve. Pulmonary embolism was found,
but no documented intracranial vascular embolism was
identified despite an episode of seizure attack.
According to the guidelines for antimicrobial therapy for
IE, at least 4e6 weeks of intravenous vancomycin therapy is
recommended.12,13 Most reported CA-MRSA IE cases were
treatedwith vancomycin, frequently combinedwith a second
antimicrobial agent such as rifampicim, gentamicin, line-
zolid, trimethoprim-salfamethozaxole, and clindamycin.
However, there are no sufficient data to support the combi-
nation therapy involving gentamicin or SXT for childhood IE.13
The mortality rate of CA-MRSA IE was 13%, which was mark-
edly lower than that of methicillin-sensitive S aureus IE and
hospital-acquired MRSA IE.6 Although CA-MRSA-associated
infections are quite common in children, only a few cases of
CA-MRSA IE have been reported in the literature.6,14
Consistent with worldwide trends, CA-MRSA was
epidemic in Taiwan and accounted for 40e70% of clinical
isolates from children with CA S aureus infections.3 Most
cases caused by CA-MRSA presented as skin and soft tissue
infections.3 CA-MRSA was also associated with invasive
diseases including bacteremia, septic arthritis, osteomye-
litis, and necrotizing pneumonia.4 The endemic CA-MRSA
clone in Taiwan was characterized as multilocus ST 59,
and carries type VT SCCmec element and PVL genes.
3,4 Chi
et al15 showed that CA-MRSA accounted for 36% (8/22) of
community-associated S aureus bacteremia and IE in
southern Taiwan. Multilocus ST59 is the major clone of CA-
MRSA isolates. The antibiogram of ST 59 CA-MRSA cloneshowed a multiresistant pattern. Most isolates were only
susceptible to vancomycin, gentamicin, trimethorpim-
sulfamethoxazole, and ciprofloxacin,3,4,16 which made it
more difficult to deal with invasive CA-MRSA infections.
In conclusion, we presented a rare case of CA-MRSA IE in
a previous healthy preschool child. The MRSA isolate
belonged to the endemic CA-MRSA clone in Taiwan. Since S
aureus remains as the predominant causative pathogen of
childhood IE, it is expected that CA-MRSA will have
a growing role in childhood IE.
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